Jan joined EMBL Ventures in 2002 and is now a Managing Director with the firm, focusing on opportunities in the life science and medical device sectors. He has been representing the firm on various portfolio boards including Endoart Medical Technology, Lipid Therapeutics, Allercra Therapeutics, and Opsona Therapeutics.
Prior to joining EMBL Ventures, Jan was a postdoctoral fellow of the Ernst Schering Research Foundation at the University of Granada, Spain, where his research focused on stem cells. Prior to that he was a fellow of the Boehringer Ingelheim Research Foundation, conducting work on molecular transport mechanisms at the Wellcome CRC in Cambridge, UK.
Education, Personal, and Fellowship
Jan holds an MS in biochemistry & molecular biology from Tubingen University, Germany and completed a PhD in genetics at the University of Cambridge, UK.
A member of Class 11, Jan was mentored by Stefan Herr at EMBL Ventures in Heidelberg, Germany.